Related Experiment Video
Updated: Sep 21, 2026

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
Published on: May 31, 2021
Quality of life and self-esteem in children treated for idiopathic short stature
Nicolet C M Theunissen1, Gerdine A Kamp, Hendrik M Koopman
1Department of Pediatrics, Leiden University Medical Center, The Netherlands.
Insights
Growth hormone treatment did not improve health-related quality of life (HRQOL) or self-esteem in children with idiopathic short stature (ISS). Pediatricians observed improvements, but children and parents reported no significant changes or even worsening HRQOL.
Area of Science:
- Pediatric Endocrinology
- Child Psychology
Background:
- Idiopathic short stature (ISS) affects children's well-being.
- Growth hormone (GH) treatment is a common intervention for ISS.
- The impact of GH on quality of life in these children requires further investigation.
Purpose of the Study:
- To assess the effect of growth hormone treatment on health-related quality of life (HRQOL) and self-esteem in children with ISS.
- To compare the perceptions of children, parents, and pediatricians regarding HRQOL changes during GH treatment.
Main Methods:
- A randomized controlled trial involving 36 prepubertal children with ISS.
- Children were assigned to either a treatment or control group.
- HRQOL and self-esteem were assessed using validated questionnaires over two years by children, parents, and pediatricians.
Main Results:
- Children with ISS generally did not exhibit lower HRQOL than the norm population, except for social functioning.
- Pediatricians reported HRQOL improvements in the treatment group.
- Children and parents reported no significant changes or even decreased HRQOL and self-esteem in the treatment group compared to the control group.
- Observed changes were more related to satisfaction with height than growth itself.
Conclusions:
- The study did not support the hypothesis that growth hormone treatment improves HRQOL in children with ISS.
- Discrepancies exist between clinician, parent, and child perspectives on treatment outcomes.
- Further research is needed to understand the complex factors influencing HRQOL in children with ISS undergoing GH treatment.
Objective:
Changes in health-related quality of life (HRQOL) and self-esteem were studied in children with idiopathic short stature (ISS) participating in a study on the effect of growth hormone treatment.
Study Design:
Prepubertal children (n = 36) with ISS were randomly assigned to a treatment or control group. Children with ISS, their parents, and the pediatrician completed HRQOL and self-esteem questionnaires 3 times in 2 years.
Results:
At the start, children with ISS did not have lower scores than the norm population, except for social functioning HRQOL. The pediatrician reported an improvement of HRQOL in the treatment group, the parents reported no change, and the children in the treatment group reported the same, or sometimes even worse, HRQOL or self-esteem than the control group. Changes related to the child's satisfaction with height and hardly to growth itself.
Conclusion:
The assumption that growth hormone treatment improves HRQOL in children with ISS could not be supported in this study.
Related Concept Videos
Nature and Nurture
Self-Evaluation: Self-Enhancement and Self-Verification
Self-Esteem
Sources of Self-Esteem I: Family Experience
Sources of Self-Esteem III: Social Comparison
Benefits of Self-Esteem

